Daihan Pharmaceutical Market Cap

Daihan Pharmaceutical has a market cap or net worth of 172.87 billion as of March 6, 2026. Its market cap has increased by 13.29% in one year.

Market Cap

172.87B

Enterprise Value

86.67B

Revenue

209.00B

Ranking

n/a

PE Ratio

5.48

Stock Price

29,400.00

Market Cap Chart

Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 172.87B, an increase of 676.60%. That is a compound annual growth rate of 8.53%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	172.87B	0.51%
Dec 30, 2025	171.99B	11.64%
Dec 30, 2024	154.06B	-5.59%
Dec 28, 2023	163.17B	-11.13%
Dec 29, 2022	183.60B	6.62%
Dec 30, 2021	172.20B	-12.90%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hana Pharm	176.66B
SAMSUNG PHARM. Co., LTD.	169.70B
Dongwha Pharm.Co.,Ltd	169.36B
Whan In Pharm	158.93B
Ilsung Is	157.85B
REYON Pharmaceutical	191.66B
AptaBio Therapeutics	192.72B
JW Lifescience	200.22B

Market Cap Rankings